Bee Venom Tag Wart Remover

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the topical treatment of warts. Patients are advised to wash the affected area and may soak the wart in warm water for 5 minutes prior to application. The area should be dried thoroughly before applying a sufficient amount of the drug to cover each wart. The application should be allowed to dry, and this procedure may be repeated once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

For the removal of common warts and plantar warts, healthcare professionals should identify the type of wart prior to treatment. Common warts, characterized by a rough "cauliflower-like" surface, are easily recognizable. In contrast, plantar warts are specifically located on the soles of the feet and are tender to touch, often displaying an interrupted footprint pattern.

The administration of the treatment should be performed as follows:

1. Preparation: Ensure the affected area is clean and dry before application. If necessary, gently file the surface of the wart with a pumice stone or emery board to enhance treatment efficacy.

2. Application: Apply the treatment directly to the wart, ensuring that it covers the entire wart surface. Care should be taken to avoid contact with surrounding healthy skin.

3. Frequency: The treatment may be applied once daily or as directed by the prescribing information. It is essential to monitor the wart's response to treatment and adjust the frequency as needed.

4. Duration: Continue treatment until the wart is completely removed, which may take several weeks. If there is no improvement after a specified period, reevaluation of the treatment plan is recommended.

Healthcare professionals should provide patients with guidance on the importance of adhering to the treatment regimen and monitoring for any adverse reactions.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. The product should not be applied to moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized treatment.

Additionally, individuals with diabetes or poor blood circulation should not use this product, as it may pose an increased risk of complications.

Keep out of reach of children. In the event of accidental ingestion, seek medical assistance or contact the Poison Control Center (1-800-222-1222) immediately.

Warnings and Precautions

For external use only; this product is flammable and must be kept away from fire and flame.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if the product is applied to irritated skin or any area that appears infected or reddened. Additionally, patients should be instructed to avoid application on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Special caution is warranted for individuals with diabetes or those who exhibit poor blood circulation, as these conditions may increase the risk of adverse effects.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire and flame.

In clinical practice, it is advised to discontinue use if irritation occurs on the skin or if the product is applied to any area that is infected or reddened. Additionally, patients should stop using the product on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

Patients with diabetes or poor blood circulation are also advised to cease use, as these conditions may increase the risk of adverse reactions.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Bee Venom Tag Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure that the product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought by contacting the Poison Control Center at 1-800-222-1222.

This product is intended for external use only and is flammable; therefore, it should be kept away from fire and flame. Caution is advised when applying to irritated skin or any area that is infected or reddened. It should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, pediatric patients with diabetes or poor blood circulation should avoid use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of BEE VENOM TAG WART REMOVER (salicylic acid cream) in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for use during pregnancy. Therefore, healthcare professionals should exercise caution when considering this product for women of childbearing potential and weigh the potential risks versus benefits. It is advisable to discuss alternative treatment options with pregnant patients or those planning to become pregnant.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact the Poison Control Center at 1-800-222-1222 for assistance. It is important for patients to understand the potential risks associated with improper use and to take necessary precautions to ensure safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from excessive heat, specifically temperatures exceeding 37°C (99°F). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Bee Venom Tag Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)